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Effects of IgM Allotype Suppression on Serum IgM
Levels, B-1 and B-2 Cells, and Antibody Responses ir
Allotype Heterozygous F1 Mice
ANN MARIE HAMILTON and JOHN F. KEARNEY"
Division of Developmental and Clinical Immunology, Department of Microbiology, University of Alabama, Birmingham,
Alabama 35294
IgM allotype heterozygous F1 mice were independently suppressed for Igh6a or Igh6b to
evaluate the contribution of B-1 and B-2 cells to natural serum IgM levels and Ab responses.
B-2 B cells expressing IgM of the suppressed allotype were evident in the spleens of
suppressed mice 4 to 6 weeks after cessation of the suppression regimen, whereas B-1 B
cells of the suppressed allotype were undetectable for up to 9 months. Although serum IgM
of the suppressed allotype was initially depleted in mice suppressed for either allotype, by
7 months of age, there were detectable levels of IgM of the suppressed allotype in the
serum; however, the levels were significantly below that found in nonsuppressed mice.
When mice were immunized with either the T-independent or T-dependent form of
phosphorylcholine, those suppressed for either allotype, and consequently depleted of B-1
B cells of that allotype, did not respond with phosphorylcholine-specific IgM of the
suppressed allotype. In contrast, when mice were immunized with 1-3 dextran, the Igh6a
allotype-suppressed mice were able to produce dextran-specific IgM of that allotype. These
results show that allotype-bearing B-1 cells of both allotypes can be effectively suppressed
by this suppression protocol and this produces long-lasting effects on B-1 cell levels and
serum IgM of the suppressed allotype. These observations reflect the derivation of the
majority of B-1 cells from fetal-neonatal precursors, which cannot be replaced by newly
emerging B-2 cells of adult origin. Their ablation by antibody treatment results in
permanent alterations to the adult B-cell repertoire.
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INTRODUCTION
The primary and secondary Ab responses to a
variety of defined Ag have been well characterized
in mice with respect to Id profiles, responder versus
nonresponder strains, and the B-cell subsets in-
volved in the Ab response. The primary response to
the T-independent Ag phosphorylcholine (PC) is
characterized by the dominant expression of the
TEPC15 (T15) Id (Cosenza and K6hler, 1972; Sher
and Cohn). Although most strains of mice are able
to make Ab specific for PC following immunization,
there is evidence that the ability to respond and the
magnitude of this response is regulated by the
heavy-chain locus (IgCH) (Lieberman et al., 1974;
"Corresponding author. Present address: 378 Wallace Tumor
Institute, University of Alabama, Alabama 35294.
Sigal et al., 1977; Cancro et al., 1978; Stall et al.,
1986). Other Ab responses have also been linked to
the IgCH lOCUS and are expressed only in mice bear-
ing particular IgCH allotypes. For example, the
anti-l-3 dextran (DEX) response characterized by
the J558 Id is absent in C57BL/6 mice and other
strains bearing the IgCH
b allotype (Blomberg et al.,
1972). Whereas these responses have been described
in genetically uniform strains of mice, the interplay
between B-1 and B-2 B cell subsets and the relation-
ship between B-1 and B-2 cells as precursors or as
regulatory cells in these IgCH-linked Ab responses in
F1 hybrid mice have not been studied.
B-1 B cells are defined as B cells expressing high
levels of surface (s) IgM, low levels of slgD, Mac-1 /,
and IL5R /; in adult mice, they are primarily located
in the peritoneal cavity rather than in spleen and
lymph nodes. B-1 B cells are further subdivided into
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B-la, those which express the CD5 marker, and
B-lb, which do not. The majority of natural serum
IgM is derived from B-1 B cells (Hardy, 1992). B-2 B
cells are igM1, IgDhi, and FcaR /; they constitute the
majority of B cells in the secondary lymphoid
organs--spleen, lymph nodes, and Peyer’s patches
(Hardy, 1992).
In this study, we have determined whether Ab
responses to the antigens PC and DEX reside solely
within the B-1 or B-2 B cell populations, and
whether B-1 B cells influence the idiotypic profile of
the responses. The experimental model uses IgCH
allotype heterozygous mice that have been treated
neonatally with either of the Igh6 allotype-specific
monoclonal antibodies (mAb). Previous studies
have shown that B cell production in mice can be
ablated by chronic administration of anti-g Ab
(Cooper et al., 1980). Lalor and colleagues (1989b)
demonstrated that neonatal suppression of the pa-
ternal IgM allotype depleted B-la B cells of the
suppressed allotype for up to 10 months after birth.
However, the B-2 and B-lb B cell populations
expressing the paternal IgM allotype returned to
normal levels in the adult, similar to previous
studies with total anti-g suppression. We have
extended the use of this model by independently
suppressing the maternal or paternal IgM allotype in
F1 mice, providing an in vivo model with the
potential to investigate the relative contributions of
B-1 versus B-2 B ce,lls of each parental allotype to
specific Ab responses and to serum Ig levels in mice
expressing two genetically distinct Ig allotypes.
RESULTS
Clearance of RS-3.1 and MB86 Occurs at
Different Rates
F1 mice derived from Igh6a dams and Igh6b sires
were subjected to IgM allotype suppression and, to
determine the length of time the suppressing Ab
could be detected, their sera were analzyed at
various intervals after birth for the presence of
either RS-3.1 or MB86, the allotype-specific .mAb
used in the suppression protocol. There were no
detectable levels of RS-3.1 in the serum of the mice
treated with this Ab 4 weeks previously (Table 1).
However, the mice that received MB86 had 3-20
gg/ml of this Igh6b-specific mAb in their circulation
at 4 and 5 weeks after the final injection. We have
duplicated these experiments with the reverse pairs
of parent, Igh6a dams, and Igh6b sires, and ob-
tained essentially the same patterns of suppression
(data not shown).
Differential Recovery of B-1 and B-2 Cells
following Allotype-Specific Suppression
CB6 F1 mice were analyzed at various ages for the
presence of B-1 and B-2 B cells of both allotypes in
the spleen and peritoneal cavity. The purpose of this
analysis was to determine the time at which B-2 and
B-1 B cells reappeared in the suppressed animals
following clearance of allotype-specific mAb. (see
earlier).
At 16 days after birth, which corresponded to 2
days after the final anti-allotype injection, all splenic
B cells of the suppressed allotype were completely
depleted, as shown by the total absence of B220
cells expressing the suppressed allotype (Fig. 1). The
total spleen cell number was approximately equal
between the nonsuppressed (78x 106) and Igh6a-
(60x 106) or Igh6b- (80x 106) suppressed CB6 F1
mice. However, the frequency of B2201g pre-B
cells in the Igh6a- and Igh6b-suppressed mice was
increased by 31-54% compared to nonsuppressed
littermates (data not shown). At 6 weeks after birth,
approximately 20% of splenic B cells from Igh6a-
suppressed CB6 F1 mice were found to express
Igh6a as compared to 33% in the nonsuppressed
TABLE
Clearance of the Allotype-Specific mAb in Allotype-Suppressed Mice
Serum Levels of Allotype Specific mAb (gg/ml)
b
Suppressed for 4 weeks 6 weeks 7 weeks 14 weeks
Igh6a 12.7 + 7.7 0 + 0 0 + 0 0 + 0
Igh6ba 25.7 + 14.0 11.9 + 7.8 2.8 + 2.8 0 + 0
aAllotype-suppressed mice bled at various times after cessation of the suppression protocol and tested in ELISA for the presence of the allotype-specific mAb.
In all of these experiments, the dams Igh6a and sires Igh6b for the CB6 (F1) offspring.
bValues represent the _+ S.D. for to 14-week-old mice.
CSera titrated Igh6a-coated plates. After overnight incubation, alkaline phosphatase-labeled goat anti-mouse IgG1 used to capture any previously bound RS-3.1
mAb. Color developed using p-nitrophenyl phosphate substrate, and the levels of RS-3.1 measured using ELISA LITE.
dSera titrated Igh6b-coated plates and analyzed for the presence of MB86 described earlier.IgM ALLOTYPE SUPPRESSION 29
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FIGURE 1. Effectiveness of allotype suppression assessed 2 days after the final injection of allotype-specific mAb. Splenocytes from
control (left panels), Igh6a-suppressed (center panels), and Igh6b-suppressed (right panels) mice were stained with FITC-labeled
anti-Igh6a (upper panels) and anti-Igh6b (lower panels), and biotin-labeled anti-B220 followed by SA-PE and analyzed by two-color
flow cytometry using a FACScan to confirm the absence of B cells expressing the suppressed allotype. The percentage of positive cells
is indicated.
group (Fig. 2A). However, the Igh6b-suppressed
CB6 F1 mice still did not possess any B-2 B cells
expressing the suppressed allotype in the spleen at
this time. B-2 cells expressing the Igh6b allotype
were not found in the spleen of Igh6b-suppressed
CB6 F1 mice until 8 weeks after birth (data not
shown).
Evaluation of the B lymphocyte composition of
the peritoneal cavity with a panel of mAb previ-
ously shown to delineate B-1 and B-2 B cells (Hardy,
1992) at 6 weeks after birth revealed that there were
no B-1 and very few, if any, B-2 B cells expressing
IgM of the suppressed allotype in either group of
IgM-suppressed mice (Fig. 2B). By 9 months after
birth, B-2 B cells of the suppressed allotype were
evident in the peritoneal cavity; however, there
were virtually no B-1 B cells of the suppressed
allotype (Fig. 3).
Immunofluorescence microscopy analysis demon-
strated the lack of plasma cells expressing Igh6a or
Igh6b in the spleens of CB6 F1 mice suppressed for
Igh6a or Igh6b, respectively, at both 6 and 8 weeks
(data not shown), which correlated with the lack of
B-1 B cells of the appropriate allotype.
Data from these analyses indicated that B-2 B cells
expressing the suppressed allotype reemerged be-
tween 6 to 8 weeks after birth. In contrast, B-1 B
cells of either suppressed allotype were absent for
up to 9 months following cessation of the allotype-
specific suppressing Ab. Despite the presence of3 A.M. HAMILTON and J. F. KEARNEY
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FIGURE 2. Splenic Igh6a B-2 B cells, but not splenic Igh6b B-2 or peritoneal Igh6a and Igh6b B-1 B cells, reemerge 4 weeks
after cessation of the suppression regimen. (A) Splenocytes and (B) peritoneal cells from control (left panels), Igh6a-suppressed (center
panels), and Igh6b-suppressed (right panels) mice were stained with FITC-labeled anti-Igh6a (upper panels of both A and B) and
anti-Igh6b (lower panels of both A and B), and biotin-labeled anti-B220 followed by SA-PE to assess the reemergence of B cells
expressing the suppressed allotype. The percentage ofpositive cells is indicated.IgM ALLOTYPE SUPPRESSION
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FIGURE 3. B-1 B cells expressing the suppressed allotype remain undetectable at 9 months after completion of the suppression
protocol. Peritoneal lymphocytes from control (left panels), Igh6a-suppressed (center panels), and Igh6b-suppressed (right panels)
mice were stained with FITC-labeled anti-Igh6a (upper panels) and anti-Igh6b (lower panels), and biotin-labeled anti-Mac-1 followed
by SA-PE to determine whether B-1 B cells expressing the suppressed allotype were evident. The percentage of positive cells is
indicated.
splenic B-2 B cells expressing surface IgM of the
suppressed allotype, there were no plasma cells ex-
pressing cytoplasmic IgM of the suppressed allotype.
Suppression of Igh6 B Cells Correlates with
Suppression of Serum IgM of the
Corresponding Igh6 Allotype
To determine whether the majority of serum IgM
was derived from B-1 B cells, as suggested by previ-
ous studies (Hardy, 1992), sera from F1 mice were
analyzed for the presence of IgM of both allotypes at
6 weeks, 14 weeks, and 7 months after birth.
At 6 weeks, the levels of Igh6b were approxi-
mately twice that of Igh6a in control animals (Fig.
4A). In mice suppressed for the Igh6a allotype, there
was no detectable Igh6a, whereas the Igh6b levels
were elevated about three fold. Conversely, in
Igh6b-suppressed mice, there was no detectable
IgM expressing the Igh6b allotype, whereas the
Igh6a levels were increased 5.5-fold. At 14 weeks,
B-2 B cells expressing either Igh6a or Igh6b were
present in the control as well as both groups of
suppressed mice (data not shown). At this time, the
levels of IgM expressing the suppressed allotype
were approximately 50 l,tg/ml in sera from either
group of suppressed mice (Fig. 4B). At 7 months of
age, mice that had been suppressed for either IgM
allotype demonstrated significant levels of the sup-
pressed allotype although at considerably lower
levels than control mice, which had almost equal
(400 l.tg/ml) amounts of both allotypes (Fig. 4C).32 A.M. HAMILTON and j. F. KEARNEY
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These findings suggest that B-2 B cells can pro-
duce small amounts (approximately 150 gg/ml) of
serum IgM, compared to control mice of the same
age, at extended periods after cessation of the
suppression protocol. However, the majority of nat-
urally occurring serum IgM still appears to originate
from B-1 B cells, particularly in younger animals.
B-2 B Cells Are Unable to Respond to the
T-Independent Form of PC
To evaluate the ability of B-2 B cells to respond to
PC, control F1 mice as well as those suppressed for
either parental allotype were immunized with a
heat-killed preparation of R36A. Seven days later,
sera were analzyed by a quantitative ELISA for the
presence of PC-specific IgM Ab of either allotype. In
the control group, the level of total PC-specific IgM
was approximately 25 gg/ml, 25-30% of which
expressed the T15 Id, as defined by reactivity with
AB1-2(Fig. 5A). Further analysis revealed that the
majority of PC-specific IgM was of the Igh6b allo-
type indicated by the low levels of PC-specific Igh6a
(Fig. 5B). Mice suppressed for the Igh6a allotype had
total PC-specific IgM levels comparable to control
mice, although the T15 portion of the response
was slightly higher (Fig. 5A). As there were no
demonstrable levels of PC-specific Igh6a Ab (Fig.
5B), the entire response was of the Igh6b allotype.
Interestingly, mice suppressed for the Igh6b allotype
responded to PC with IgM levels similar to the other
two groups, but the T15 Id was almost completely
absent (Figs. 5A and 5B). The PC-specific response
in these mice was of the Igh6a allotype.
Due to the lack of AB1-2 reactivity in this latter
group, the T15 portion of the PC-specific IgM
response was further analyzed for expression of the
VHS107 heavy and Vk22 light chains required for
the T15 Id, using a quantitative ELISA with the
TC139-2 anti-T15 Id mAb. This mAb detects all
PC-specific Ab that are T15 despite the presence
of junctional diversity between either VH-D or D-JH
joins (Kearney et al., 1983). The results of this
analysis indicated that Igh6b-suppressed mice did
FIGURE 4. Natural serum IgM levels of the suppressed allotype
reach approximately 50% of levels in nonsuppressed mice after 7
months. Sera from (A) 6-week-old, (B) 14-week-old, (C) 7-month
old mice were titrated on RS-3.1- and MB86-coated plates and
analyzed by an ELISA for Igh6a (open squares) and Igh6b (closed
circles) levels, respectively. Values are given for individual mice
in each group shown.IgM ALLOTYPE SUPPRESSION 33
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FIGURE 5. Allotype-suppressed mice only produce PC-specific Ab of the nonsuppressed allotype when challenged with the
T-independent form of PC. Mice were immunized with S. pneumoniae (strain R36A) and sera analyzed by an ELISA for (A) total
PC-specific IgM and (B) PC-specific Igh6a. Sera were titrated on plates coated with PC-BSA or AB1-2 (anti-T15 Id mAb). A polyclonal
goat anti-mouse IgM Ab or RS-3.1 was used to determine the total IgM or Igh6a PC-specific Ab response, respectively. Values for
PC-specific (open squares) and T15 (closed circles) Ab responses from individual control, Igh6a-, and Igh6b-suppressed mice are
shown.
not produce PC-specific IgM of the correct heavy-
and light-chain pair in order to generate the domi-
nant T15 Id (Fig. 6).
At the time when these mice were immunized,
B-2 B cells expressing Igh6a were evident in the
spleens of Igh6a-suppressed mice (Fig. 2A). How-
ever, there were no B-1 B cells of the suppressed
allotype in the peritoneal cavity of either group of
suppressed mice (Fig. 2B). These data indicate that
although the B-2 B cells expressing Igh6a were
present in Igh6a-suppressed mice, these mice did
not respond to the T-independent form of PC.
Therefore, in this situation, the B-2 B cells regener-
ating in the suppressed mice did not respond to this
antigen.
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FIGURE 6. The T15 PC-specific Ab response is absent in
Igh6b-suppressed mice. Sera from R6A immunized mice were
analyzed for PC-specific Ab reactive with TC139-2 in an ELISA.
Values shown correspond to individual control (closed squares),
Igh6a- (open cirlces), and Igh6b- (closed circles) suppressed mice.
B-2 B Cells in Allotype-Suppressed F1 Mice can
Respond to c1-3 DEX
In order to determine whether B-2 B cells can
respond to DEX, F1 mice were immunized with
c1-3 DEX, and 7 days later, the serum was analyzed
for the presence of DEX-specific IgM of either
allotype. The total DEX-specific IgM response in
nonsuppressed mice was approximately 75 tg/ml,
of which 50% expressed the normally dominant
J558 Id detected by reactivity with EB3-7 (Fig. 7).
Mice suppressed for Igh6a demonstrated similar
levels of DEX-specific and J558 IgM Ab to those in
the nonsuppressed mice. Whereas the DEX-specific
IgM response in Igh6b-suppressed mice was slightly
elevated over the nonsuppressed mice, the percent-
age of J558
/ DEX-specific Ab was greatly reduced.
To determine the Id of the anti-DEX response in
Igh6b-suppressed mice, the serum was then ana-
lyzed for the presence of the minor M104E Id. With
one exception, almost 100% of the total DEX-34 A.M. HAMILTON and J. F. KEARNEY
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FIGURE 7. Igh6a B-2 B cells can respond to DEX. Mice were
immunized with DEX and sera analzyed by an ELISA for the
presence of DEX-specific (open squares) and J558 (closed
circles) IgM. Plates coated with EB3-7 (anti-J558 Id mAb) were
used to determine the levels of J558 Id. Values correspond to
individual control, Igh6a-, and Igh6b-suppressed mice.
specific IgM response in Igh6b-suppressed mice
expressed the M104E Id (Fig. 8). The percentages of
DEX-specific Ab expressing the M104E Id in non-
suppressed and Igh6a-suppressed mice were ap-
proximately 50% and 30%, respectively.
The primary IgM response to DEX in all three
groups of mice was of the Igh6a allotype, as there
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FIGURE 8. Igh6b-suppressed mice produce significant levels of
M104E DEX-specific IgM. Sera from DEX immunized mice were
also analyzed by an ELISA for the presence of the minor M104E
Id on plates coated with SJL18.1 (anti-M104E Id mAb). Values
correspond to individual control (closed squares), Igh6a- (open
circles), and Igh6b (closed circles) suppressed mice.
were no detectable levels of DEX-specific Igh6b and
the amount of total ,1 DEX-specific Ab equaled the
total Igh6a DEX-specific Ab in all groups tested (data
not shown). In these experiments, mice were immu-
nized after B-2 B cells expressing Igh6a had re-
emerged in those animals suppressed for Igh6a, but
before B-1 B cells could be found in the peritoneal
cavity, so it is clear from this data that the B-2 B-cell
population is able to respond to DEX.
The Response to a T-Dependent Form of PC
also Appears to Reside within the B-1 B Cell
Population
F1 mice were primed with KLH and 14 days later
immunized with PC-KLH, a T-dependent form of
PC, to determine whether allotype suppression of
B-1 B cells affects the Ab response and the idiotypic
profile of the response to this Ag. Seven days after
immunization, sera were analyzed for the presence
of PC-specific IgM of either allotype similar to the
method used for detecting PC-specific IgM in R36A
immunized mice (see earlier). The total level of
PC-specific IgM in nonsuppressed mice was approx-
imately 100 tg/ml, of which almost 100% ex-
pressed the dominant T15 Id (Fig. 9A). The majority
of the response was of the Igh6b allotype, as
indicated by the low levels of PC-specific Igh6a, that
did not express T15 (Fig. 9B). Mice suppressed for
the Igh6a allotype had total PC-specific IgM levels
similar to nonsuppressed mice (Fig. 9A). All of the
PC-specific IgM response in these mice was of the
Igh6b allotype because there was no demonstrable
levels of Igh6a PC-specific IgM (Fig. 9B). Mice
suppressed for Igh6b had approximately 50% lower
levels of PC-specific IgM (Fig. 9A), which was
entirely of the Igh6a allotype (Figs. 9A and 9B).
Interestingly, the PC-specific IgM response to PC-
KLH in these mice was not of the dominant T15 Id.
In IgCH a/b F1 mice, the response to PC appears to
be dominated by the Igh6b allotype, as illustrated in
this data and the responses to the T-independent
form of PC (see earlier). Therefore, suppression of
the Igh6a allotype has little effect on the PC-specific
Igh6b response. However, when mice were sup-
pressed for Igh6b, they did not produce significant
levels of PC-specific Igh6a and there was consider-
able inhibition of the dominant T15 Id. These results
also indicated that the response to the T-dependent
form of PC resides within the B-1 B cell population,
as evidenced by the total absence of PC-specific Ab
expressing the suppressed allotype.IgM ALLOTYPE SUPPRESSION 35
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Allotype-suppressed mice only produce PC-specific Ab of the nonsuppressed allotype when challenged with the
T-dependent form of PC. Mice were immunized with PC-KLH and sera analyzed by ELISA for the presence of (A) total PC-specific
and (B) PC-specific Igh6a. Values for PC-specific (open squares) and T15 (closed cirlces) Ab responses from individual control,
Igh6a-, and Igh6b- suppressed mice are shown.
DISCUSSION
In order to study the interplay of B cells expressing
genetically distinct Ig alleles, we chose to indepen-
dently suppress either the maternal or paternal IgM
allotype in F1 mice, thereby providing a means to
investigate the relative contribution of B-1 and B-2 B
cells of each parental allotype to specific Ab re-
sponses and to serum IgM levels. Similar to the
findings of Lalor and colleagues (1989b), our results
demonstrate temporary suppression of B-2 B cells
expressing the suppressed allotype. In Igh6a-
suppressed mice, B-2 B cells expressing Igh6a reap-
peared in the spleen 4 weeks after cessation of the
suppression protocol. However, B-2 B cells express-
ing Igh6b were not found in the spleen of Igh6b-
suppressed mice until 6 weeks after completion of
the suppression regimen. The temporal differences
in the reappearance of B-2 cells expressing either
Igh6a or Igh6b in appropriately suppressed mice
may be due in part to the ability of the mice to clear
the allotype-specific suppressing mAb from the
circulation. RS-3.1 was effectively cleared almost 3
weeks sooner then MB86, which correlates with the
earlier reappearance in the spleens of these mice of
B-2 B cells expressing Igh6a. We have no explana-
tion for these differences because we propagated
and purified these antibodies, both of the IgG1
isotype in the same way.
These results support previous studies that have
demonstrated selective suppression of the paternal
B-1 and B-2 cells in allotype heterozygous mice
(Lalor et al., 1989b). When CB6 F1 mice were
injected neonatally with AF6-78.25, an Igh6b-
specific mAb, B-2 B cells expressing Igh6b began to
reappear in the peripheral lymphoid organs shortly
after the disappearance of the suppressing Ab,
reaching normal numbers by 6 months. Although
the authors suggest that there is complete suppres-
sion of B-1 B cells expressing Igh6b for up to 1 year,
more recently (Herzenberg and Kantor, in prepara-
tion) it was shown that B-lb B cells expressing
Igh6b reappeared in the peritoneal cavity at 8
months (Lalor et al., 1989a).
In contrast to these observations, we demonstrate
the complete suppression of B-1 B cells for up to 9
months after cessation of the suppression protocol.
Neither B-lb nor B-la B cells reappear in either
Igh6a- or Igh6b-suppressed mice, as evidenced by
the complete absence of Mac-1
/ IgM
hi B-1 B cells
expressing the suppressed allotype in the peritoneal
cavity. These data support the existence of a feed-
back mechanism operating in the peritoneal cavity,
which regulates the development of B-1 B cells of
both allotypes from progenitor cells (Lalor et al.,
1989a).
A recent study in rabbits demonstrated that al-
most all peripheral B cells express the CD5 mem-
brane glycoprotein suggesting that all rabbit
peripheral B cells are of the B-1 type (Raman and
Knight, 1992). Previous allotype suppression studies
performed in Ig heterozygous rabbits (Mage, 1967;36 A.M. HAMILTON and J. F. KEARNEY
Harrison and Mage, 1973; Eskinazi et al., 1979)
produced results similar to those in mice, as reported
by Lalor (1989b) and herein. In the rabbit studies,
neonatal or in utero injection of either light-chain or
heavy-chain allotype-specific Ab resulted in long-
term suppression of B cells expressing that allotype.
These findings further support the concept of a
feedback mechanism operating to inhibit the subse-
quent production of B-1 B cells from progenitor cells
or selection of B-1 cells into the B cell pool.
Data from several studies indicate that the major-
ity of naturally occurring serum IgM is produced by
B-1 B cells (Herzenberg et al., 1986; F6rster and
Rajewsky, 1987; Hardy, 1992). Our allotype-
suppression model enabled us to evaluate the
amounts of seurm IgM contributed by B-1 and B-2
B cells. Results in allotype-suppressed mice con-
firmed that the majority of serum IgM originates
from B-1 B cells and that B-2 B cells produce only
relatively small amounts of serum IgM after the
elapse of an extended period of time from the
cessation of allotype suppression. Although B-2 B
cells expressing the suppressed allotype were evi-
dent in the spleen of suppressed mice at 4 to 6
weeks after completion of the suppression regimen,
low levels of serum IgM of the suppressed allotype
did not appear for another 6 to 8 weeks. The reason
for the delay in production of serum IgM by B-2 B
cells in allotype-suppressed mice is not obvious. It is
likely that B-1 B cells are activated to IgM secretion
by internal networks, whereas B-2 cells may be
selected into the repertoire by environmental Ag
(Bos et al., 1989). Therefore, production of large
amounts of serum IgM in unimmunized mice by B-2
cells, as demonstrated by Thomas-Vaslin and col-
leagues (1992), may correlate with the degree and
type of bacterial and viral flora of the mice being
analyzed.
Previous cell-transfer experiments have suggested
that responses to two T-independent Ag, PC and
DEX, reside within the B-1 B cell subset and that B-2
B cells are unable to respond to these Ag (F6rster
and Rajewsky, 1987; Thomas-Vaslin et al., 1992).
Furthermore, anti-iI-10 treatment of mice, which
resulted in the depletion of B-1 B cells, ablated the
response to DEX (Ishida et al., 1992). In our exper-
iments, F1 allotype heterozygous mice were sup-
pressed for either the paternal or maternal IgM
allotype shortly after birth and without continuous
treatment, thereby ensuring minimal manipulation
of the adult immune system. Using these allotype-
suppressed mice, we were then able to investigate
the contribution of B-2 B cells to PC- and DEX-
specific Ab responses as well as to determine the
effect of B-1 B cell depletion on these responses and
their idiotypic profiles. The results obtained from
the analysis of these specific Ab responses shed light
on the role of clonal competition between B cells for
expression of each allotype and provide several
explanations for previously observed phenomena in
both cell-transfer studies and anti-cytokine-treated
mice.
IgCHa/b F1 mice have previously been shown to
be low responders to PC (Lieberman et al., 1974). In
these mice, the PC-specific IgM response appears to
be dominated by the Igh6b allotype, as demon-
strated by the control values in Fig. 5. Although B-2
B cells expressing the suppressecl allotype were
present in the appropriate group of allotype-
suppressed mice, there was no detectable levels of
PC-specific IgM of the suppressed allotype in the
serum. These results are consistent with those ob-
tained by Masmoudi and colleagues (1990), which
demonstrated that the Ab response to the T-
independent form of PC resides solely within the
B-1 B cell population.
There was no significant change in the levels of
PC-specific Igh6b or T15
/ anti-PC in mice sup-
pressed for the Igh6a allotype. However, in mice
suppressed for Igh6b, the total Igh6a anti-PC re-
sponse was essentially similar to control values, but
it did not express the dominant T15 Id.
In an earlier study by Sigal and colleagues (1977),
the splenic PC-specific precursor frequency of 4 to 5
day CB6 F1 neonates was significantly higher than
that of BALB/c neonates of the same age. This
indicated that PC-specific precursors arise earlier in
CB6 F1 mice compared to those in parental BALB/c
mice, although in this study, it was not determined
whether these precursors expressed the Igh6b allo-
type. During the developmental window in which
PC-specific precursors originate in CB6 F1 mice, it is
likely that B cells expressing the Igh6b allotype are
generated first, thereby inhibiting by feedback com-
petition the selection of T15
/ PC-reactive B cells
expressing the Igh6a allotype into the newly form-
ing repertoire of F1 mice. In the mice suppressed for
Igh6b, the failure of PC-specific Igh6a to express the
dominant T15 Id may also be due to the inactivation
by suppression of the earlier arising regulatory
fetal-derived B cells that are normally predomi-
nantly Igh6b in F1 mice. In previous studies, we
have shown that such B cells are involved in theIgM ALLOTYPE SUPPRESSION 37
development of T15 dominance (Vakil et al., 1986;
Vakil and Kearney, 1988).
In each group of mice tested, the Ab response to
the T-dependent form of PC was almost identical in
all aspects to the Ab response to the T-independent
form of this Ag. These results, as well as those of
Taki and colleagues (1992), indicate that the ability
to produce an Ab response to this Ag resides solely
within the B-1 B cell subset regardless of how the
Ag is presented to the B cell.
The responses of Igh6a-suppressed mice indicated
that B-2 B cells were able to respond to DEX and
that the response was of the dominant J558 Id.
These results contrast with previous studies that
suggested that DEX-specific responses arose from
B-1 B cells (F6rster and Rajewsky, 1987). However,
we cannot exclude the possibility that there may
have been other DEX-responsive Igh6a B cells in
anatomically distinct sites.
Experiments performed by F6rster and Rajewsky
(1987) involved the transfer of BALB/c Igh6a adult
bone marrow or peritoneal cells into CB.20 Igh6b
newborn mice. When recipient mice were immu-
nized with DEX, those that received adult peritoneal
cavity B-1 B cells were able to respond to this Ag,
although the idiotypic profile was not determined.
Mice that received bone marrow as a source of
progenitors for B-2 B cells were unable to respond to
DEX. Additionally, other previous studies (Weiler et
al., 1985) demonstrated active suppression of the
DEX-specific Igh6a Ab response by Igh6b lympho-
cytes when BALB/c bone marrow was transferred
into nude mice expressing the Igh6b allotype on a
BALB/c genetic background. It is likely that the
demonstrated suppressive action of host Igh6b lym-
phocytes would explain the lack of donor Igh6a
DEX-specific Ab response in the mice receiving bone
marrow cells in the cell-transfer experiments (FOr-
ster and Rajewsky, 1987) similar to that observed by
Weiler and colleagues (1985). However, because the
peritoneal cavity is not seeded with lymphocytes
until 8 days after birth (Hamilton and Kearney, in
preparation), there are no Igh6b lymphocytes in the
peritoneal cavity of recipient mice at the time of
peritoneal cell transfer. Therefore, there are no
Igh6b peritoneal lymphocytes to compete for the
seeding of the DEX-specific Igh6a precursors con-
tained within the transferred peritoneal B-1 cells.
Thus, the combined results of these transfer exper-
iments may be interpreted as another example of
the clonal competition that occurs in the establish-
ment of the peritoneal population of B-1 cells.
In other experiments, anti-IL-10 treatment com-
pletely ablated the response to DEX in BALB/c mice,
suggesting that the B-2 B cells remaining in the
B-l-depleted mice did not respond to DEX (Ishida et
al., 1992). Coadministration of anti-IL-10 and anti-/
interferon reduced the ability of anti-IL-10 to de-
plete mice of peritoneal B-1 cells. The mechanism
responsible for the depletion of peritoneal B-1 B
cells in these mice appears to involve multiple
cell-cytokine interactions. Therefore, the inability of
B-2 B cells to respond to DEX in mice treated with
anti-IL-10 Ab may be due to complex cell-cytokine
interactions as yet undefined.
In Igh6b-suppressed mice, the majority of the
Igh6a Ab response to DEX expressed the normally
minor M104E Id. It was of interest that-the M104E
Id values surpassed the total anti-DEX response.
We have seen this occasionally in other experi-
ments in BALB/c mice, and it may reflect idiotype
expressed on other than DEX-specific antibody.
Our previous ontogenic studies have demonstrated
that the first detectable DEX-specific B cells express
the M104E Id, whereas J558 DEX-specific B cells
arose later in ontogeny and then dominated the
response in adults (Stohrer and Kearney, 1984).
Similar to the results observed with PC, it is likely
that in normal F1 mice, proposed regulatory B cells
expressing the Igh6b allotype that are generated
first promote the expansion of J558 DEX-specific
B cells expressing the Igh6a allotype at the expense
of the M104E Id
/ B cells. However, in the F1 mice
suppressed for Igh6b, the failure to generate DEX-
specific, J558
/ Igh6a may be due to the failure of
these B cells to be selected because the earlier aris-
ing Igh6b regulatory B cells are absent or function-
ally inactivated as a result of the allotype-specific
suppresion. Therefore, the earliest generated
M104E DEX-specific B cell precursors would re-
main as the dominant clones.
The independent suppression of the maternal or
paternal IgM allotype in F1 mice provided a means
to investigate the contribution of B cell subsets to
serum IgM levels and specific Ab responses. These
results indicate a division of Ab responsiveness to
certain Ag between B-1 and B-2 B cell subsets and
that the depletion of B-1 B cells early in develop-
ment appears to influence the idiotypic profile of the
Ab response from B-2 B cells. Properly chosen
parental strains could provide a usable model for the
role of early interactions between these B cell sub-
sets in other Ag systems.38 A.M. HAMILTON and J. F. KEARNEY
MATERIALS AND METHODS
Animals
BALB/c (IgCHa) and C57BL/6 (IgCHb) mice were
obtained from Jackson Laboratories (Bar Harbor,
ME) and bred in our animal facilities to produce the
BALB/cxC57BL/6 (CB6) and C57BL/6xBALB/c
(B6C) F1 mice used herein. There were no differ-
ences in Ab responses from either CB6 or B6C F1
mice. Results observed only in CB6 F1 mice are
indicated in the text. Adult F1 mice were analyzed
by serologic tests for viral and mycoplasma infec-
tions, in vitro cultures for bacterial and mycoplasma
pathogens, and histologic examination for evidence
of disease, as previously described (Parker et al.,
1989). All results were negative.
Antibodies
The mouse .anti-mouse Igh6a mAb-producing hy-
bridoma (RS-3.1) (Schuppel et al., 1987) was ob-
tained from Dr. T. Imanishi-Kari. The mouse anti-
mouse Igh6b mAb (Nishikawa et al., 1986)
producing hybridoma (MB86) was obtained from
Dr. A. Radbruch. Purified Ab was obtained by
passing hybridoma culture supematant over a goat
anti-mouse IgG1 (Southern Biotechnology Associ-
ates, Birmingham, AL) coupled CNBr-activated
sepharose 4B (Pharmacia, Piscataway, NJ) affinity
column, followed by elution with 0.1 M glycine/
HC1 (pH 2.8). The purified Ab was then dialyzed
against PBS and filter sterilized for injection. Bioti-
nylation of Ab was performed using standard pro-
tocols (Pierce, Rockford, IL). Conjugation of RS-3.1
and MB86 to FITC was carried out by Southern
Biotechnology Associates. FITC-conjugated AF6-
78.25 (Stall and Loken, 1984), unlabeled R6-71, and
biotinylated R40-97 were purchased from Pharmin-
gen (San Diego). FITC-conjugated goat anti-mouse
IgM, streptavidin-phycoerythrin (SA-PE), and
streptavidin-Texas Red (SA-TR) were purchased
from Southern Biotechnology Associates. All other
mAb used in this study are described in Table 2.
Suppression Regimen
Mating of BALB/c and C57BL/6 mice produced the
IgCHa/b allotype heterozygous F1 mice used in this
study. The suppression regimen has been previously
described (Lalor et al., 1989b). Briefly, neonatal mice
were given i.p. injections of 50 tg of either RS-3.1
or MB86 in PBS within 24 hr of birth. A second
injection of 100 g of the appropriate Ab was given
i.p. at 7 days after birth followed by a final injection
of 150 g at 14 days after birth. The Ab, when
administered at this dosage (300 gg total), is detect-
able in the circulation for at least 5 to 6 weeks (Lalor
et al., 1989b). Control F1 mice received PBS alone.
ELISA Analysis of Circulating Levels of Igh6
Allotype-Specific Ab
Mice were bled at 4, 5, and 6 weeks after birth and
serum levels of RS-3.1 and MB86 determined using
TABLE 2
mAb Used in this Study
Antibody Name Specificity Isotype Source
RS-3.1
MB86
AF6-78.25
14.8
11-26c
M1/70.15.11.5
53.7.313
R52.120
B3B4
R6-71
R40-97
BH8
AB1-2
TC139-2
H1-3
EB3-7
M104E
SJL18.1
Igh6a
Igh6b
Igh6b
B220
mouse IgD
Mac-1 (CDllb)
mouse CD5
mouse IL5R
mouse FceR
mouse IgM
mouse IgM
PC
T15 Id
T15 Id
al-3 DEX
J558 Id
al-3 DEX
M104E
mouse /lk
mouse
mouse
rat /2bk
rat
rat 3,2nk
rat /2ak
rat ’lk
rat 3,2ak
rat ’lk
rat 3,2ck
mouse tk
mouse
rat
mouse tk
mouse ,1k
mouse
mouse tk
T. Imanishi-Kari;
Schuppel et al., 1987
A. Radbruch; Nishikawa et al., 1986
Stall and Loken, 1984
Kincade et al., 1981
D. Bole
Springer et al., 1979
Ledbetter and Herzenberg, 1979
R. Palacios; Rolink et al., 1989
M. Kehry
Pharmingen
Pharmingen
Pollok et al., 1984
Kearney et al., 1983
J. Kenny; Desaymard et al., 1984
M. Elliott
Stohrer et al., 1983
J. Eldridge
Stohrer et al., 1983IgM ALLOTYPE SUPPRESSION 39
a quantitative ELISA. Ninety-six-well microtiter
plates (Costar, Cambridge, MA) were coated with 2
g/ml of a monoclonal IgM Ab of either the Igh6a
or Igh6b allotype for 4 hr at 37C. PBS containing
1% BSA and 0.1% sodium azide was then used as a
blocking agent. After washing with PBS, the plates
were incubated at 4C overnight with serial dilu-
tions of serum samples from individual mice or
known amounts of RS-3.1 or MB86, which served
as standards for the detection of each in the serum
of suppressed mice. The plates were then washed
with PBS, followed by incubation with alkaline
phosphatase-labeled goat anti-mouse IgG1 Ab
(Southern Biotechnology Associates) at 37C for
2hr. Color was developed using p-nitrophenyl phos-
phate (Sigma, St. Louis) as a substrate. The OD405
absorbance values were read using a Titertek Mul-
tiscan PLUS (FLOW Laboratories, McClean, VA).
Serum concentrations of RS-3.1 and MB86 were
calculated using the ELISA LITE computer program
(Meddata, New York).
Immunofluorescence Staining of Peripheral
Lymphocytes
Following isolation of single-cell suspensions of CB6
F1 spleen or peritoneal cavity, 2 x 105 cells were
incubated with either FITC-conjugated goat anti-
mouse IgM, RS-3.1-FITC, or AF6-78.25-FITC for 20
min. The cells were washed in PBS containing 1%
crystallized BSA (Sigma) and 0.05% sodium azide,
and then incubated with either 14.8-biotin, 11-26c-
biotin, M1/70.15.11.5-biotin, R52.120-biotin, B3B4-
biotin, or 53.7.313-biotin followed by SA-PE. The
cells were then washed and analyzed by flow
cytometry using the FACScan Consort 30 program
(Becton Dickinson, Mountain View, CA).
Immunofluorescence Staining of Fixed Tissues
Mice were killed by cervical dislocation and their
spleens removed. Approximately one-third of each
spleen was immersed in O.C.T. embedding com-
pound (Miles Scientific, Elkhart, IN) and snap fro-
zen in a plastic ’boat’ floated on the surface of liquid
nitrogen. Where possible, sections were cut imme-
diately; otherwise, tissue blocks were stored at
-70C. Four micron sections were cut using a
Minotome cryostat (IEC, Needham Heights, MA).
Following fixation, cryostat sections were allowed
to air dry. After overnight incubation in a desiccator
at 4C, the tissue section was covered with 100 tl
MB86-FITC plus RS-3.1-biotin, and the slide was
placed in a humidified chamber for 20 min at room
temperature. The section was then washed with
PBS and subsequently incubated with 100 1 SA-TR
for 20 min as before. The slides were then washed
a final time and cover slips were mounted using
Elvanol (Southern Biotechnology Associates). Sec-
tions were examined using a fluorescence micro-
scope (Leitz, Germany).
ELISA Analysis of Serum IgM
Mice were bled at 4, 5, and 6 weeks after birth and
at various other times as mentioned in the text. The
serum levels of Igh6a and Igh6b were determined
using a quantitative ELISA, as described before with
the following modifications. Plates were coated with
2 tg/ml of either RS-3.1 or MB86 for 4 hr at 37C,
thus permitting the detection of serum Igh6a and
Igh6b levels, respectively. Known quantities of mAb
that express either the Igh6a or Igh6b allotypic
determinant were used as standards.
Immunization Protocol
A heat-killed preparation of S. pneumoniae (strain
R36A) was prepared as follows. R36A was grown in
3% Todd-Hewitt broth containing 0.5% yeast ex-
tract at 37C until an ODs00 of 0.6 was reached. The
bacteria were then heat killed at 56-60C for 1 hr
followed by extensive washing with cold PBS. An
OD420 was taken to quantitate the number of heat-
killed bacteria per milliliter of solution. Dextran
B-1355S (35% c1-3 linkages), derived from L. me-
senteroides, was a gift from Dr. M. Slodki. Approx-
imately 6 to 14 weeks after birth, allotype-
suppressed mice were given i.p. injections of
2 x 108 R36A and 100 tg Dextran B-1355S in
saline and bled 7 days later. Following a 3 to 4 week
rest period, the same mice were given s.c. injections
of 50 tg keyhole limpet hemocyanin (KLH)
(Calbiochem-Behring Corp, LaJolla, CA) dissolved
in sterile PBS. After 14 days, the mice were then
administered i.p. injections of 100 tg PC-KLH (pro-
vided by Dr. J. Eldridge) in PBS and bled 7 days
later.
Antigens Used for ELISA
PC- and DEX-BSA were prepared as described
elsewhere (Eisen, 1964; Chesebro and Metzger,
1972).40 A.M. HAMILTON and J. F. KEARNEY
ELISA Analysis of Serum Ab Responses
PC- and DEX-specific Ab in sera of immunized mice
were determined using a quantitative ELISA as
described before with the following variations.
Plates were coated with 2 tg/ml of either PC-BSA,
DEX-BSA, or monoclonal anti-Id Ab (listed in Table
2) for 4 hr at 37C. Following incubation with serum
samples or mAb standards, plates were incubated
with either alkaline phosphatase-labeled goat anti-
mouse IgM for 2 hr at 37C or RS-3.1-biotin,
MB86-biotin, or R40-97-biotin for 4 hr at 37C.
Subsequent to washing with PBS, plates that re-
ceived biotin-labeled Ab were incubated with
streptavidin-alkaline phosphatase (Southern Bio-
technology Associates) overnight at 4C. The con-
centration of Ab was calculated using ELISA LITE.
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